Merck Access Program for PREVYMIS (letermovir)

The Merck Access Program identifies insurance benefits, explains out-of-pocket costs and shares copay options. It also refers eligible patients to the Merck Patient Assistance Program, which gives PREVYMIS free to eligible people, mainly the uninsured.

Help offered: insurance navigation / benefits verification, copay savings card, free drug for uninsured (PAP), financial assistance referral.

Eligibility changes often. Confirm details on the official program page linked below before applying.